2nd International Conference & Exhibition on Pharmacovigilance & Clinical Trials

OMICS Publishing Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials 2013 during November 18-19, 2013 at San Antonio, USA.

The first International Conference and Exhibition on Pharmacovigilance & Clinical Trials was held in DoubleTree by Hilton, Chicago North shore, USA, October 21-23, 2012 with a theme "Safer Drugs and Good Clinical Practice" which brought together large and medium pharmaceutical, biotech companies, leading Universities, Clinical research institutions and dignitaries from Quality & Regulatory departments of FDA.

OMICS Group proudly announces, 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials, which will bring together a unique and International mix of Pharmaceutical, Biotech and Clinical research companies, leading Universities and Research Institutes working in the field of Pharmacovigilance and drug safety, making the conference a perfect platform to share experience, foster collaborations across industry and academia and share emerging scientific updates across the globe by means of thought provoking Keynote presentations, oral talks and poster presentations opportunities.

Special OMICS Journals

All accepted abstracts will be published in either the Journal of Pharmacovigilance, Journal of Clinical & Experimental Pharmacology or Journal of Clinical Trials.

Pharmacovigilance and its Challenges

• Role of pharmacovigilance in health regulation
• International collaboration and new pharmacovigilance legislation
• Role of pharma industries in the improvement of pharmacovigilance system
• Fatality of pharmacovigilance failure
• Detection & evaluation of drug safety signals

Role of Clinical Trials

• Data collection and quality control
• Alternative trials design and models
• Multi center trials and monitoring
• Multi center trials and monitoring

Clinical Trials on Diseases

• Emerging technology in clinical trials
• Recent clinical trials on Parkinsons disease
• Clinical trials on cancer
• Applications of biomarkers in clinical trials
• Emerging technology in clinical trials

Adverse Drug Reactions

• Assessing & reporting adverse drug reactions
• Reduction of adverse drug reaction by nano technology
• Expected and un-expected drug reactions and its reporting
• Drugs in human pregnancy and nursing
• Pharmacotherapy and Pharmacogenomics
• Post marketing reports on adverse effects

Drug Interactions

• Advances of pharmacokinetic interactions
• Advances of pharmacodynamic interactions
• Drug and substance abuse
• Drug-drug interactions
• Pharmacoenvironmentology

Pharmacy Practices and Its Challenges

• Pharmacy practice and its guidelines
• Challenges in compounding and dispensing practice
• Drug toxicity and drug safety measures
• Pharmacoepidemiology of drug shortages

Regulatory Affairs

• Role of regulatory affairs in pharmacovigilance
• Role of regulatory agencies in safe medicines and medical devices
• Risk minimization tools

Risk Management: New Approaching Paradigm for Pharmacovigilance

• Information technology in pharmacovigilance and promoting companies
• Review of softwares used in pharmacovigilance and clinical trials
• Risk communication: Interface between pharmacovigilance, sales and marketing
• Risk management versus recent market withdrawal
• Monitoring unlicensed, off labels and orphan drugs

Clinical Research and Statistics

• Guidelines for clinical research and its statistics
• Advanced Information technology in clinical trials and promoting companies
• Data mining concepts and techniques

Strategies for Growth in Pharma Environment

• Strategic development towards FDA approval
• Advances in changing pharmacovigilance regulation system
• Post market product surveillances